Literature DB >> 27481119

[Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

U Kiltz1, R Alten2, M Fleck3, K Krüger4, B Manger5, U Müller-Ladner6, H Nüßlein7, M Reuss-Borst8, A Schwarting9, H Schulze-Koops10, A Tausche11, J Braun12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27481119     DOI： 10.1007/s00393-016-0147-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  184 in total

Review 1.  Treatment target and followup measures for patients with gout: a systematic literature review.

Authors:  Mariano Andrés; Francisca Sivera; Louise Falzon; Désirée M van der Heijde; Loreto Carmona
Journal:  J Rheumatol Suppl       Date:  2014-09

2.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

Review 3.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

4.  Ultrasonography in gout: a case-control study.

Authors:  Sébastien Ottaviani; Pascal Richette; Anne Allard; Jérémy Ora; Thomas Bardin
Journal:  Clin Exp Rheumatol       Date:  2012-08-29       Impact factor: 4.473

5.  Double-blind trial of feprazone and phenylbutazone in acute gout.

Authors:  J A Reardon; A Stockman; L G Darlington; J T Scott
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

6.  Comparison of drug adherence rates among patients with seven different medical conditions.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

7.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

8.  Serum urate during acute gout.

Authors:  Naomi Schlesinger; Josephine M Norquist; Douglas J Watson
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

9.  Gout and the risk for incident heart failure and systolic dysfunction.

Authors:  Eswar Krishnan
Journal:  BMJ Open       Date:  2012-02-15       Impact factor: 2.692

Review 10.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228
View more
  6 in total

Review 1.  [Methodological approaches in the development of clinical guidelines].

Authors:  K Albrecht
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 2.  [Gouty arthritis].

Authors:  A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

Review 3.  [Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüsslein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A K Tausche; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 4.  What Is the Evidence for Treat-to-Target Serum Urate in Gout?

Authors:  David Bursill; Nicola Dalbeth
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

Review 5.  Treatment Options for Gout.

Authors:  Bettina Engel; Johannes Just; Markus Bleckwenn; Klaus Weckbecker
Journal:  Dtsch Arztebl Int       Date:  2017-03-31       Impact factor: 5.594

Review 6.  [Dual-energy computed tomography diagnostics for gout].

Authors:  H J Rech; A Cavallaro
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.